☰

Gavin B. Bart, Ph.D. - Publications

Affiliations: 
2013 Experimental & Clinical Pharmacology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Pharmacology, Medicine and Surgery, Mental Health
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Bart G, Jaber M, Giang LM, Brundage RC, Korthuis PT. Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability. Drug and Alcohol Dependence. 241: 109696. PMID 36402052 DOI: 10.1016/j.drugalcdep.2022.109696  0.562
2021 Bart G, Giang LM, Yen H, Hodges JS, Brundage RC. Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study. Drug and Alcohol Dependence. 227: 109025. PMID 34482033 DOI: 10.1016/j.drugalcdep.2021.109025  0.549
2021 King C, Cook R, Giang LM, Bart G, Hoffman K, Waddell EN, Korthuis PT. Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam. Journal of Substance Abuse Treatment. 108451. PMID 33962813 DOI: 10.1016/j.jsat.2021.108451  0.326
2020 Edsall A, Dinh TTT, Mai PP, Hoffman K, Nguyen HT, Khuyen TT, Trang NT, Bart G, Giang LM, Korthuis PT. Provider Perspectives on Integration of Substance Use Disorder and HIV Care in Vietnam: A Qualitative Study. The Journal of Behavioral Health Services & Research. PMID 32940824 DOI: 10.1007/S11414-020-09730-4  0.331
2020 Ford BR, Bart G, Grahan B, Shearer RD, Winkelman TNA. Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder. Journal of Addiction Medicine. PMID 32868682 DOI: 10.1097/Adm.0000000000000726  0.41
2020 Shearer RD, Howell BA, Bart G, Winkelman TNA. Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018 Drug and Alcohol Dependence. 214: 108162. PMID 32652380 DOI: 10.1016/J.Drugalcdep.2020.108162  0.378
2020 King C, Giang LM, Bart G, Kunkel L, Korthuis PT. HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: baseline results from the BRAVO study. Bmc Public Health. 20: 421. PMID 32228522 DOI: 10.1186/S12889-020-08538-3  0.354
2020 Bart GB, Saxon A, Fiellin DA, McNeely J, Muench JP, Shanahan CW, Huntley K, Gore-Langton RE. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report. Addiction Science & Clinical Practice. 15: 4. PMID 31948487 DOI: 10.1186/S13722-020-0180-2  0.359
2018 Admon LK, Bart G, Kozhimannil KB, Richardson CR, Dalton VK, Winkelman TNA. Amphetamine- and Opioid-Affected Births: Incidence, Outcomes, and Costs, United States, 2004-2015. American Journal of Public Health. e1-e7. PMID 30496001 DOI: 10.2105/Ajph.2018.304771  0.305
2018 Samuels EA, D'Onofrio G, Huntley K, Levin S, Schuur JD, Bart G, Hawk K, Tai B, Campbell CI, Venkatesh AK. A Quality Framework for Emergency Department Treatment of Opioid Use Disorder. Annals of Emergency Medicine. PMID 30318376 DOI: 10.1016/J.Annemergmed.2018.08.439  0.371
2018 Bart G. Ethnic differences in psychosocial factors in methadone maintenance: Hmong versus non-Hmong. Journal of Ethnicity in Substance Abuse. 17: 108-122. PMID 29120275 DOI: 10.1080/15332640.2017.1371656  0.357
2015 Bart G, Lenz S. Significantly lower prevalence of psychopathology in Asian compared to non-Asian methadone maintained patients Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.063  0.349
2014 Bart G, Lenz S, Straka RJ, Brundage RC. Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic study. Drug and Alcohol Dependence. 145: 185-93. PMID 25456329 DOI: 10.1016/J.Drugalcdep.2014.10.014  0.541
2014 Bart G, Lenz S, Wyman Z, Bart B. Low incidence of cardiac diagnoses in methadone patients: No association with QTc Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.052  0.316
2013 Bart G. Collaborative addiction research in the United States and Asia. Journal of Food and Drug Analysis. 21: S106-S108. PMID 25242874 DOI: 10.1016/J.Jfda.2013.09.045  0.315
2013 Ducat E, Ray B, Bart G, Umemura Y, Varon J, Ho A, Kreek MJ. Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone. Addiction Biology. 18: 325-31. PMID 21507151 DOI: 10.1111/J.1369-1600.2011.00313.X  0.334
2012 Bart G. Maintenance medication for opiate addiction: the foundation of recovery. Journal of Addictive Diseases. 31: 207-25. PMID 22873183 DOI: 10.1080/10550887.2012.694598  0.385
2012 Bart G, Wang Q, Hodges JS, Nolan C, Carlson G. Superior methadone treatment outcome in Hmong compared with non-Hmong patients. Journal of Substance Abuse Treatment. 43: 269-75. PMID 22285835 DOI: 10.1016/J.Jsat.2011.12.006  0.35
2007 Williams TJ, LaForge KS, Gordon D, Bart G, Kellogg S, Ott J, Kreek MJ. Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence. Addiction Biology. 12: 496-502. PMID 17559549 DOI: 10.1111/J.1369-1600.2007.00069.X  0.307
2006 Bart G, LaForge KS, Borg L, Lilly C, Ho A, Kreek MJ. Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2313-7. PMID 16794569 DOI: 10.1038/Sj.Npp.1301128  0.313
2005 Bart G, Schluger JH, Borg L, Ho A, Bidlack JM, Kreek MJ. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2254-62. PMID 15988468 DOI: 10.1038/Sj.Npp.1300811  0.362
2005 Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacological Reviews. 57: 1-26. PMID 15734726 DOI: 10.1124/Pr.57.1.1  0.38
2005 Bart G, Kreek MJ, Ott J, LaForge KS, Proudnikov D, Pollak L, Heilig M. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 417-22. PMID 15525999 DOI: 10.1038/Sj.Npp.1300598  0.323
2004 Kreek MJ, Schlussman SD, Bart G, Laforge KS, Butelman ER. Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA. Neuropharmacology. 47: 324-44. PMID 15464148 DOI: 10.1016/J.Neuropharm.2004.07.024  0.356
2004 Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J, Kreek MJ. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Molecular Psychiatry. 9: 547-9. PMID 15037869 DOI: 10.1038/Sj.Mp.4001504  0.339
2003 Bart G, Borg L, Schluger JH, Green M, Ho A, Kreek MJ. Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects. The Journal of Pharmacology and Experimental Therapeutics. 306: 581-7. PMID 12730354 DOI: 10.1124/Jpet.103.050682  0.335
2003 Schluger JH, Bart G, Green M, Ho A, Kreek MJ. Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 985-94. PMID 12700714 DOI: 10.1038/Sj.Npp.1300156  0.312
Show low-probability matches.